{"transactions":[{"id":4636385,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-06T21:05:50.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":6893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":905993,"source":{"system":"sec-edgar","filing":"0001171843-26-006472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777962/000117184326006472/ownership.xml","form_type":"4"}},{"id":670892,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-09-01T22:12:25.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":899100,"source":{"system":"sec-edgar","filing":"0001171843-26-005844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326005844/ownership.xml","form_type":"4"}},{"id":696897,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-08-04T21:02:08.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":5324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":893386,"source":{"system":"sec-edgar","filing":"0001171843-26-005208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326005208/ownership.xml","form_type":"4"}},{"id":717290,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-07-02T21:05:48.000Z","date":"2026-07-02","kind":"grant","planned":false,"acquired":true,"shares":3378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":888062,"source":{"system":"sec-edgar","filing":"0001171843-26-004451","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326004451/ownership.xml","form_type":"4"}},{"id":735864,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-06-16T21:03:05.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":153550,"price":5.21,"value":799995.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50."}],"balance_after":884684,"source":{"system":"sec-edgar","filing":"0001171843-26-004151","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326004151/ownership.xml","form_type":"4"}},{"id":756748,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-06-01T21:00:12.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":1671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":731134,"source":{"system":"sec-edgar","filing":"0001171843-26-003842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003842/ownership.xml","form_type":"4"}},{"id":758451,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-05-29T21:00:38.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":96913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":729463,"source":{"system":"sec-edgar","filing":"0001171843-26-003797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003797/ownership.xml","form_type":"4"}},{"id":795321,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-05-02T01:01:45.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":1159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":632550,"source":{"system":"sec-edgar","filing":"0001171843-26-002942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326002942/ownership.xml","form_type":"4"}},{"id":810212,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-04-10T21:02:20.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":2578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":631391,"source":{"system":"sec-edgar","filing":"0001171843-26-002373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326002373/ownership.xml","form_type":"4"}},{"id":850409,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-10T21:02:16.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.5989,"value":6598.9,"ownership":{"direct":true},"balance_after":628813,"source":{"system":"sec-edgar","filing":"0001171843-26-001463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001463/ownership.xml","form_type":"4"}},{"id":855511,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-06T22:01:15.000Z","date":"2026-03-05","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.9,"value":39000.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":402702,"source":{"system":"sec-edgar","filing":"0001171843-26-001390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001390/ownership.xml","form_type":"4"}},{"id":857973,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-05T22:01:11.000Z","date":"2026-03-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.256,"value":42560.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":392702,"source":{"system":"sec-edgar","filing":"0001171843-26-001370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001370/ownership.xml","form_type":"4"}},{"id":860779,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-04T22:01:45.000Z","date":"2026-03-03","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.63,"value":36300.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":382702,"source":{"system":"sec-edgar","filing":"0001171843-26-001329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001329/ownership.xml","form_type":"4"}},{"id":865433,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-03T22:00:18.000Z","date":"2026-03-02","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.2796,"value":2279.6,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":372702,"source":{"system":"sec-edgar","filing":"0001171843-26-001302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001302/ownership.xml","form_type":"4"}},{"id":865432,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-03T22:00:18.000Z","date":"2026-03-02","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2,"value":4000.0,"ownership":{"direct":true},"balance_after":627813,"source":{"system":"sec-edgar","filing":"0001171843-26-001302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001302/ownership.xml","form_type":"4"}},{"id":873587,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:05:59.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.2232,"value":66696.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.22 to $2.2295 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":371702,"source":{"system":"sec-edgar","filing":"0001171843-26-001267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001267/ownership.xml","form_type":"4"}},{"id":873586,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:05:59.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":10016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":625813,"source":{"system":"sec-edgar","filing":"0001171843-26-001267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001267/ownership.xml","form_type":"4"}},{"id":873585,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:05:59.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":20571,"price":1.5789,"value":32479.5519,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.58 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":615797,"source":{"system":"sec-edgar","filing":"0001171843-26-001267","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001267/ownership.xml","form_type":"4"}},{"id":873584,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-02T22:01:34.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":82236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2025."}],"balance_after":595226,"source":{"system":"sec-edgar","filing":"0001171843-26-001266","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326001266/ownership.xml","form_type":"4"}},{"id":924554,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-02T22:01:02.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":11168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":512990,"source":{"system":"sec-edgar","filing":"0001171843-26-000567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326000567/ownership.xml","form_type":"4"}},{"id":950281,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-06T02:00:34.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":10444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":501822,"source":{"system":"sec-edgar","filing":"0001171843-26-000069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326000069/ownership.xml","form_type":"4"}},{"id":983256,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-12-02T23:01:01.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":8766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":491378,"source":{"system":"sec-edgar","filing":"0001171843-25-007725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325007725/ownership.xml","form_type":"4"}},{"id":1005607,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-11-06T23:13:46.000Z","date":"2025-11-03","kind":"grant","planned":false,"acquired":true,"shares":6968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":482612,"source":{"system":"sec-edgar","filing":"0001171843-25-007107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325007107/ownership.xml","form_type":"4"}},{"id":1024125,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-03T20:31:53.000Z","date":"2025-10-02","kind":"grant","planned":false,"acquired":true,"shares":5908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":475644,"source":{"system":"sec-edgar","filing":"0001171843-25-006274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325006274/ownership.xml","form_type":"4"}},{"id":1041262,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-09-13T01:00:15.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":5981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":469736,"source":{"system":"sec-edgar","filing":"0001171843-25-005895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325005895/ownership.xml","form_type":"4"}},{"id":1076064,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-08-05T01:30:48.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":6802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":463755,"source":{"system":"sec-edgar","filing":"0001171843-25-005016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325005016/ownership.xml","form_type":"4"}},{"id":1094375,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-07-03T01:01:43.000Z","date":"2025-07-02","kind":"grant","planned":false,"acquired":true,"shares":7186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":456953,"source":{"system":"sec-edgar","filing":"0001171843-25-004300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325004300/ownership.xml","form_type":"4"}},{"id":1127250,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-06-03T01:21:02.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":7644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":449767,"source":{"system":"sec-edgar","filing":"0001171843-25-003590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003590/ownership.xml","form_type":"4"}},{"id":1127249,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-06-03T01:21:02.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":263200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 166,287 shares shall vest monthly in equal proportions over twelve (12) months, commencing on the grant date and (ii) 96,913 shares shall vest in equal proportions over thirty-six (36) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, of which (i) 166,287 shares shall vest monthly in equal proportions over twelve (12) months, commencing on the grant date and (ii) 96,913 shares shall vest in equal proportions over thirty-six (36) months, commencing on the grant date."}],"balance_after":442123,"source":{"system":"sec-edgar","filing":"0001171843-25-003590","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325003590/ownership.xml","form_type":"4"}},{"id":1157129,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-05-06T21:28:21.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":6392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":178923,"source":{"system":"sec-edgar","filing":"0001171843-25-002829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325002829/ownership.xml","form_type":"4"}},{"id":1178908,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-04-03T21:25:30.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":5784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":172531,"source":{"system":"sec-edgar","filing":"0001171843-25-001997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325001997/ownership.xml","form_type":"4"}},{"id":1235280,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-04T01:00:55.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":6339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":166747,"source":{"system":"sec-edgar","filing":"0001171843-25-001217","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325001217/ownership.xml","form_type":"4"}},{"id":1266750,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B-1 Convertible Preferred Shares","published_at":"2025-02-14T22:01:59.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 11, 2025, the Reporting Person purchased in a private placement, 100 shares of the Issuer's newly designated Series B-1 Convertible Preferred Shares (the \"Preferred Shares\"), stated value $10,000 per share for an aggregate purchase price of $1.0 million. The Preferred Shares are immediately convertible at $1.92 per share, to the extent that after giving effect to such conversion the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Preferred Shares are perpetual and therefore have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Preferred Share is convertible at any time, at the option of the holder, into a number of common shares determined by dividing the stated value of the Preferred Share ($10,000 per share), plus all other amounts due in respect of such Preferred Share (excluding distributions), by the conversion price at the time of conversion."}],"balance_after":100,"derivative":{"exercise_price":1.92,"exercise_date":"2025-02-12","underlying":"Common Shares","underlying_shares":520833},"source":{"system":"sec-edgar","filing":"0001171843-25-000868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000868/ownership.xml","form_type":"4"}},{"id":1283883,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-02-05T00:32:04.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":8264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":160408,"source":{"system":"sec-edgar","filing":"0001171843-25-000620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000620/ownership.xml","form_type":"4"}},{"id":1309792,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-01-06T23:01:31.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":8476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":152144,"source":{"system":"sec-edgar","filing":"0001171843-25-000056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184325000056/ownership.xml","form_type":"4"}},{"id":1344491,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-12-04T02:08:20.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":6420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":143668,"source":{"system":"sec-edgar","filing":"0001171843-24-006707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324006707/ownership.xml","form_type":"4"}},{"id":1368380,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-11-13T02:29:21.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":137248,"source":{"system":"sec-edgar","filing":"0001171843-24-006302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324006302/ownership.xml","form_type":"4"}},{"id":1378038,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2024-11-02T00:49:53.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":326560,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 30, 2024, the Reporting Person purchased in a private placement, (i) 150 shares of the Issuer's newly designated Series A-1 Convertible Preferred Shares (the \"Preferred Shares\"), stated value $10,000 per share and (ii) warrants (the \"Warrants\") to purchase up to an aggregate of 326,560 common shares. The Preferred Shares are immediately convertible, and the Warrants are immediately exercisable, at $3.445 per share, in each case, to the extent that after giving effect to such conversion and/or exercise the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer. The Preferred Shares and the Warrants are being sold together in a fixed combination of one Preferred Share and a Warrant to purchase a number of common shares equal to 75% of the common shares underlying the Preferred Share at a combined purchase price of $10,272.13."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pardeep Medicine Professional Corporation is wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":326560,"derivative":{"exercise_price":3.445,"exercise_date":"2024-10-30","expiration_date":"2029-10-30","underlying":"Common Stock","underlying_shares":326560},"source":{"system":"sec-edgar","filing":"0001171843-24-005964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005964/ownership.xml","form_type":"4"}},{"id":1378037,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A-1 Convertible Preferred Shares","published_at":"2024-11-02T00:49:53.000Z","date":"2024-10-30","kind":"grant","planned":false,"acquired":true,"shares":150,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 30, 2024, the Reporting Person purchased in a private placement, (i) 150 shares of the Issuer's newly designated Series A-1 Convertible Preferred Shares (the \"Preferred Shares\"), stated value $10,000 per share and (ii) warrants (the \"Warrants\") to purchase up to an aggregate of 326,560 common shares. The Preferred Shares are immediately convertible, and the Warrants are immediately exercisable, at $3.445 per share, in each case, to the extent that after giving effect to such conversion and/or exercise the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer. The Preferred Shares and the Warrants are being sold together in a fixed combination of one Preferred Share and a Warrant to purchase a number of common shares equal to 75% of the common shares underlying the Preferred Share at a combined purchase price of $10,272.13."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Preferred Shares are perpetual and therefore have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Preferred Share is convertible at any time, at the option of the holder, into a number of common shares determined by dividing the stated value of the Preferred Share ($10,000 per share), plus any accrued and unpaid dividends, by the conversion price at the time of conversion. Until the three-year anniversary of the day of issuance, holders of Preferred Shares are entitled to an annual return equal to 10% of the stated value per Preferred Share payable by the issuance of common shares at the conversion price upon a buy-back by the Issuer, liquidation or on conversion at the conversion price (calculated daily)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pardeep Medicine Professional Corporation is wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":150,"derivative":{"exercise_price":3.445,"exercise_date":"2024-10-30","underlying":"Common Stock","underlying_shares":435414},"source":{"system":"sec-edgar","filing":"0001171843-24-005964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005964/ownership.xml","form_type":"4"}},{"id":1393780,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-10-03T01:30:22.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":132618,"source":{"system":"sec-edgar","filing":"0001171843-24-005464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005464/ownership.xml","form_type":"4"}},{"id":1417478,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-09-04T00:00:18.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":3055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":129318,"source":{"system":"sec-edgar","filing":"0001171843-24-005045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324005045/ownership.xml","form_type":"4"}},{"id":1442517,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-08-03T01:01:14.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":3317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":126263,"source":{"system":"sec-edgar","filing":"0001171843-24-004413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184324004413/ownership.xml","form_type":"4"}},{"id":1459395,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-07-04T01:00:13.000Z","date":"2024-07-02","kind":"grant","planned":false,"acquired":true,"shares":4015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":122946,"source":{"system":"sec-edgar","filing":"0001654954-24-008617","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424008617/section16.xml","form_type":"4"}},{"id":1491491,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-06-05T01:01:06.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":4785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":118931,"source":{"system":"sec-edgar","filing":"0001654954-24-007354","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424007354/section16.xml","form_type":"4"}},{"id":1531671,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share","published_at":"2024-05-02T01:30:56.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":3083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":114146,"source":{"system":"sec-edgar","filing":"0001654954-24-005413","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424005413/section16.xml","form_type":"4"}},{"id":1552811,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-02T23:02:41.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":3253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":111063,"source":{"system":"sec-edgar","filing":"0001654954-24-004189","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424004189/section16.xml","form_type":"4"}},{"id":1561939,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-03-25T19:00:59.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4,"value":20000.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":341702,"source":{"system":"sec-edgar","filing":"0001654954-24-003606","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495424003606/section16.xml","form_type":"4"}},{"id":1606321,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-01T23:20:34.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":2765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":107810,"source":{"system":"sec-edgar","filing":"0001654954-24-002509","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424002509/section16.xml","form_type":"4"}},{"id":1660903,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-03T02:30:45.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":2978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."}],"balance_after":105045,"source":{"system":"sec-edgar","filing":"0001654954-24-001264","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424001264/section16.xml","form_type":"4"}},{"id":1679794,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-12T22:30:48.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":2908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023."}],"balance_after":102067,"source":{"system":"sec-edgar","filing":"0001654954-24-000528","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495424000528/section16.xml","form_type":"4"}},{"id":1814704,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-08-04T20:18:55.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":99300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units (\"RSUs\"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023."}],"balance_after":694112,"source":{"system":"sec-edgar","filing":"0001654954-23-010166","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423010166/section16.xml","form_type":"4"}},{"id":1824007,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:45:45.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001654954-23-009594","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009594/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824677,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:31:19.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the date of grant."}],"balance_after":120000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001654954-23-009535","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423009535/section16.xml","form_type":"4"}},{"id":2124515,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."}],"balance_after":114131,"derivative":{"exercise_price":1,"underlying":"Common Share","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124514,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":114131,"derivative":{"exercise_price":1,"underlying":"Common Shares","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124513,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."}],"balance_after":114131,"derivative":{"exercise_price":1.5,"underlying":"Common Share","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124512,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":114131,"derivative":{"exercise_price":1.5,"underlying":"Common Shares","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124511,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":228262,"price":1.125,"value":256794.75,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."}],"balance_after":228262,"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124510,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":228262,"price":1.125,"value":256794.75,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2356914,"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2214865,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-07-05T13:38:11.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":20000,"price":1.6039,"value":32078.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.52 to $1.6622. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":594812,"source":{"system":"sec-edgar","filing":"0001654954-22-009259","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422009259/section16.xml","form_type":"4"}},{"id":2251523,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-05-31T09:00:28.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":5000,"price":1.9198,"value":9599.0,"ownership":{"direct":true},"balance_after":574812,"source":{"system":"sec-edgar","filing":"0001654954-22-007684","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422007684/section16.xml","form_type":"4"}},{"id":2256860,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-05-25T12:13:13.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":2000,"price":1.7998,"value":3599.6,"ownership":{"direct":true},"balance_after":569812,"source":{"system":"sec-edgar","filing":"0001654954-22-007509","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422007509/section16.xml","form_type":"4"}},{"id":2311350,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-04-01T10:56:52.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":2000,"price":2.9858,"value":5971.6,"ownership":{"direct":true},"balance_after":567812,"source":{"system":"sec-edgar","filing":"0001654954-22-004413","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422004413/section16.xml","form_type":"4"}},{"id":2313010,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-31T10:52:48.000Z","date":"2022-03-30","kind":"purchase","acquired":true,"shares":2000,"price":3.0491,"value":6098.2,"ownership":{"direct":true},"balance_after":565812,"source":{"system":"sec-edgar","filing":"0001654954-22-004245","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422004245/section16.xml","form_type":"4"}},{"id":2314266,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-30T12:47:38.000Z","date":"2022-03-29","kind":"purchase","acquired":true,"shares":2000,"price":3.0168,"value":6033.6,"ownership":{"direct":true},"balance_after":563812,"source":{"system":"sec-edgar","filing":"0001654954-22-004118","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422004118/section16.xml","form_type":"4"}},{"id":2323201,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-21T10:27:12.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":2000,"price":3.8496,"value":7699.2,"ownership":{"direct":true},"balance_after":561812,"source":{"system":"sec-edgar","filing":"0001654954-22-003483","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003483/section16.xml","form_type":"4"}},{"id":2324805,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-18T11:26:06.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":1603,"price":3.264,"value":5232.192,"ownership":{"direct":true},"balance_after":559812,"source":{"system":"sec-edgar","filing":"0001654954-22-003409","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003409/section16.xml","form_type":"4"}},{"id":2324804,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-18T11:26:06.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":397,"price":3.2498,"value":1290.1706,"ownership":{"direct":true},"balance_after":558209,"source":{"system":"sec-edgar","filing":"0001654954-22-003409","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003409/section16.xml","form_type":"4"}},{"id":2330870,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-16T11:17:57.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":2000,"price":2.799,"value":5598.0,"ownership":{"direct":true},"balance_after":557812,"source":{"system":"sec-edgar","filing":"0001654954-22-003224","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003224/section16.xml","form_type":"4"}},{"id":2335596,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-14T13:59:18.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":5000,"price":3.0589,"value":15294.5,"ownership":{"direct":true},"balance_after":555812,"source":{"system":"sec-edgar","filing":"0001654954-22-003095","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003095/section16.xml","form_type":"4"}},{"id":2335595,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-14T13:59:18.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":2000,"price":3.1788,"value":6357.6,"ownership":{"direct":true},"balance_after":550812,"source":{"system":"sec-edgar","filing":"0001654954-22-003095","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003095/section16.xml","form_type":"4"}},{"id":2339954,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-10T11:10:53.000Z","date":"2022-03-09","kind":"purchase","acquired":true,"shares":1500,"price":3.0464,"value":4569.6,"ownership":{"direct":true},"balance_after":548812,"source":{"system":"sec-edgar","filing":"0001654954-22-002850","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422002850/section16.xml","form_type":"4"}},{"id":2347190,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-08T00:37:01.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":49000,"derivative":{"exercise_price":3.71,"expiration_date":"2032-02-28","underlying":"Common Shares","underlying_shares":49000},"source":{"system":"sec-edgar","filing":"0001654954-22-002646","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495422002646/section16.xml","form_type":"4"}},{"id":2739378,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T21:04:02.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":120000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-04-22","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001654954-21-004637","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495421004637/section16.xml","form_type":"4"}},{"id":2769400,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-29T13:02:54.000Z","date":"2020-03-29","kind":"purchase","acquired":true,"shares":2000,"price":5.23,"value":10460.0,"ownership":{"direct":true},"balance_after":547312,"source":{"system":"sec-edgar","filing":"0001654954-21-003384","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495421003384/section16.xml","form_type":"4"}},{"id":2770727,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-26T11:44:03.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":3000,"price":5.25,"value":15750.0,"ownership":{"direct":true},"balance_after":545312,"source":{"system":"sec-edgar","filing":"0001654954-21-003334","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495421003334/section16.xml","form_type":"4"}},{"id":2772072,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-25T14:43:47.000Z","date":"2021-03-24","kind":"purchase","acquired":true,"shares":5000,"price":5.16,"value":25800.0,"ownership":{"direct":true},"balance_after":542312,"source":{"system":"sec-edgar","filing":"0001654954-21-003274","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495421003274/section16.xml","form_type":"4"}},{"id":2989875,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common share warrants (Right to buy)","published_at":"2020-11-06T10:00:13.000Z","date":"2020-11-05","kind":"other","acquired":false,"shares":4628,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common shares","underlying_shares":4628},"source":{"system":"sec-edgar","filing":"0001654954-20-011925","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420011925/section16.xml","form_type":"4"}},{"id":2989874,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2020-11-06T10:00:13.000Z","date":"2020-11-05","kind":"other","acquired":true,"shares":4628,"price":4,"value":18512.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2128652,"source":{"system":"sec-edgar","filing":"0001654954-20-011925","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420011925/section16.xml","form_type":"4"}},{"id":3006845,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-10-14T19:54:09.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":60000,"derivative":{"exercise_price":7.44,"expiration_date":"2030-10-13","underlying":"Common shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001654954-20-011144","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000165495420011144/section16.xml","form_type":"4"}},{"id":3027104,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2020-09-18T09:23:36.000Z","date":"2020-09-17","kind":"other","acquired":true,"shares":371727,"ownership":{"direct":false,"nature":"Held by 1968160 Ontario Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pardeep Nijhawan acquired 100% of the capital stock of 1968160 Ontario Inc. which holds 371,727 common shares of the issuer, pursuant to the foreign equivalent of a domestic relations order."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":371727,"source":{"system":"sec-edgar","filing":"0001654954-20-010224","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420010224/section16.xml","form_type":"4"}},{"id":3132391,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2020-05-28T12:19:56.000Z","date":"2020-05-26","kind":"purchase","acquired":true,"shares":3000,"price":2.9797,"value":8939.1,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation (1)"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2124024,"source":{"system":"sec-edgar","filing":"0001654954-20-006029","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420006029/section16.xml","form_type":"4"}},{"id":3201070,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8975,"value":1897.5,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2121024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201069,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.828,"value":1828.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2120024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201068,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8978,"value":1897.8,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2119024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201067,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8599,"value":1859.9,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2118024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201066,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8899,"value":1889.9,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2117024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3313685,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T21:42:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":4628,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":4628,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":4628},"source":{"system":"sec-edgar","filing":"0001654954-20-000314","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420000314/section16.xml","form_type":"4"}},{"id":3313684,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T21:42:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":6942,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":6942,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":6942},"source":{"system":"sec-edgar","filing":"0001654954-20-000314","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420000314/section16.xml","form_type":"4"}},{"id":3313683,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-01-10T21:42:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":9255,"price":4.11,"value":38038.05,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2116024,"source":{"system":"sec-edgar","filing":"0001654954-20-000314","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420000314/section16.xml","form_type":"4"}},{"id":3453066,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T22:51:13.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":91,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."},{"field":"shares","element":"transactionShares","label":"F5","text":"This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option vests and becomes exercisable 1/3 on December 28, 2019, and monthly thereafter through December 28, 2021."}],"balance_after":1620,"derivative":{"exercise_price":2.16,"expiration_date":"2028-12-28","underlying":"Common Shares","underlying_shares":91},"source":{"system":"sec-edgar","filing":"0001777962-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/primary_doc.xml","form_type":"4"}},{"id":3453065,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T22:51:13.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":2667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."},{"field":"shares","element":"transactionShares","label":"F5","text":"This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests and becomes exercisable 1/3 on September 26, 2018, and monthly thereafter through September 26, 2020."}],"balance_after":47490,"derivative":{"exercise_price":2.16,"expiration_date":"2027-09-26","underlying":"Common Shares","underlying_shares":2667},"source":{"system":"sec-edgar","filing":"0001777962-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/primary_doc.xml","form_type":"4"}},{"id":3453064,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2019-07-30T22:51:13.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":12588,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The Digestive Health Clinic Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the \"Issuer\") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. (\"Edesa\"), and the shareholders of Edesa.  The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":224094,"source":{"system":"sec-edgar","filing":"0001777962-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/primary_doc.xml","form_type":"4"}},{"id":3453063,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2019-07-30T22:51:13.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":118345,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the \"Issuer\") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. (\"Edesa\"), and the shareholders of Edesa.  The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2106769,"source":{"system":"sec-edgar","filing":"0001777962-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/primary_doc.xml","form_type":"4"}},{"id":3453062,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2019-07-30T22:51:13.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":30183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents additional common shares or options to purchase common shares, as applicable, of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the \"Issuer\") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. (\"Edesa\"), and the shareholders of Edesa.  The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."}],"balance_after":537312,"source":{"system":"sec-edgar","filing":"0001777962-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000003/primary_doc.xml","form_type":"4"}},{"id":3493763,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T00:58:20.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":1529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"shares","element":"transactionShares","label":"F5","text":"This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option vests and becomes exercisable 1/3 on 12/28/19, and monthly thereafter through 12/28/21."}],"balance_after":1529,"derivative":{"exercise_price":0.38,"expiration_date":"2028-12-28","underlying":"Common Shares","underlying_shares":1529},"source":{"system":"sec-edgar","filing":"0001777962-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/primary_doc.xml","form_type":"4"}},{"id":3493762,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-12T00:58:20.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":44823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In Canadian currency."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"shares","element":"transactionShares","label":"F5","text":"This option was issued in replacement of an option to purchase shares of Edesa."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vests and becomes exercisable 1/3 on 9/26/18, and monthly thereafter through 9/26/20."}],"balance_after":44823,"derivative":{"exercise_price":0.38,"expiration_date":"2027-09-26","underlying":"Common Shares","underlying_shares":44823},"source":{"system":"sec-edgar","filing":"0001777962-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/primary_doc.xml","form_type":"4"}},{"id":3493761,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2019-06-12T00:58:20.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":211506,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The Digestive Health Clinic Inc."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the \"Issuer\") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. (\"Edesa\") and the shareholders of Edesa Biotech Inc."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":211506,"source":{"system":"sec-edgar","filing":"0001777962-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/primary_doc.xml","form_type":"4"}},{"id":3493760,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2019-06-12T00:58:20.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":1988424,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the \"Issuer\") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. (\"Edesa\") and the shareholders of Edesa Biotech Inc."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":1988424,"source":{"system":"sec-edgar","filing":"0001777962-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/primary_doc.xml","form_type":"4"}},{"id":3493759,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2019-06-12T00:58:20.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":507129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.)(the \"Issuer\") issued in the share exchange transaction that was completed on June 7, 2019, pursuant to that certain Share Exchange Agreement, dated March 7, 2019, by and among the Issuer, Edesa Biotech Inc. (\"Edesa\") and the shareholders of Edesa Biotech Inc."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019."}],"balance_after":507129,"source":{"system":"sec-edgar","filing":"0001777962-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1540159/000177796219000002/primary_doc.xml","form_type":"4"}}]}